Introduction and Aims: Melanoma is resistant to standard chemotherapies and few therapeutic measures improve
patient survival in the metastatic stage of the disease. CYP1B1, a member of the cytochrome
P450 enzyme family, appears to be over-expressed in a number of human malignancies
whilst exhibiting little protein expression in normal tissues. CYP1B1 protein expression
was investigated in primary and metastatic melanoma to assess its potential as a target
for pro-drug therapy.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Plastic, Reconstructive & Aesthetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
O23
Identification
Copyright
© 2007 Published by Elsevier Inc.
